Here's one of the hardest communication lessons for academic scientists wanting to break into the biotech industry... A paper. Is. Not. A. Result. A grant. Is. Not. A. Result. I know. It hurts to read it. The thing that all of your colleagues and university admin have said is the only thing that matters...it's not really a result. Does that make your academic work irrelevant? Absolutely not. What it does mean, is that you need to change what you're focusing on when communicating your value. 𝗛𝗲𝗿𝗲'𝘀 𝗮 𝗹𝗶𝘀𝘁 𝗼𝗳 𝘁𝗵𝗶𝗻𝗴𝘀 𝘁𝗵𝗮𝘁 𝗔𝗥𝗘 𝗿𝗲𝘀𝘂𝗹𝘁𝘀 -method you developed -intellectual property -infrastructure you built -device prototypes you invented -biological mechanisms you determined -operational improvements If you read the above and don't know what I'm talking about, it's ok. I can teach you how to translate your academic mindset into the above. You are valuable. You just need to learn to communicate in a way that people in the business world can understand. If you have questions, put them in the comments below. 👇 #biotechjobs #biotech #scientist
Ali Divan, Ph.D.’s Post
More Relevant Posts
-
Here's one of the hardest lessons for my academic colleagues wanting to break into the biotech industry... A paper. Is. Not. A. Result. A grant. Is. Not. A. Result. I know. It hurts to read it. The thing that all of your colleagues and university admin have said is the only thing that matters...it's not really a result. Does that make your academic work irrelevant? Absolutely not. What it does mean, is that you need to change what you're focusing on when communicating your value. 𝗛𝗲𝗿𝗲'𝘀 𝗮 𝗹𝗶𝘀𝘁 𝗼𝗳 𝘁𝗵𝗶𝗻𝗴𝘀 𝘁𝗵𝗮𝘁 𝗔𝗥𝗘 𝗿𝗲𝘀𝘂𝗹𝘁𝘀 -method you developed -intellectual property -infrastructure you built -device prototypes you invented -biological mechanisms you determined -operational improvements If you read the above and don't know what I'm talking about, it's ok. I can teach you how to translate your academic mindset into the above. You are valuable. you just need to learn to communicate in a way that people in the business world can understand. If you have questions, put them in the comments below. 👇 #biotechjobs #biotech #phd
To view or add a comment, sign in
-
Industrial transition is a current concern in academia, probably a major reason of the not-so-talked-about postdoc crunch in many labs. The perks are higher of course, and with the limits of biologics being pushed far and far up by automation, high-throughputs and AI, getting a satisfying job is becoming easier than getting tenure. But what does academia need to do for rejuvenating its impact? In a recent (well, a month old, honestly) encounter with Josh McGinnis for a Sci-Comm lecture at the University of Oregon, we talked about the emerging importance of promoting DIY biologists on different platforms that could make hard-boiled research a more accessible format of appreciating science and its nuances. The event was a brainchild of the Alliance for Diversity in Science and Engineering (UO Chapter) and jointly organized by The Centre for Science Communication Research (UO). Josh's venture, EverymanBio, is already a known name in the circuit and surely a successful one. But more than being an individual success story, this is also an example of an alternate approach to academic pursuit for exploring natural wonders. They need the best training to do science, not the best certification. And once their endeavor is in motion, academia can lend its reviewing platform to validate the findings, and a good research can fetch good funding through many options! Grants are limited, discoveries ain't. If we could tap on this potential resource, decentralize research opportunities, encourage self-trained scientists as any other scientist, may be transitions would stop being a concern and just be a constant.
To view or add a comment, sign in
-
-
Diverse Horizons in Biotech! In the dynamic world of biotech, our journey is often shaped by unexpected turns. Meet Amyra, a recent graduate who, despite excelling in lab experiments, ventured beyond the conventional. Amyra explored bioinformatics, decoding complex data with her analytical skills. In market research, her scientific background became a strategic asset, uncovering lucrative opportunities. Transitioning to publishing, she bridged the gap between researchers and the public. Amyra's foray into marketing showcased her ability to craft compelling narratives, boosting product visibility and advancing scientific knowledge. Intrigued by regulatory affairs, she ensured the safety and efficacy of emerging technologies. Amyra's journey proves that biotech isn't limited to labs – it's a vast landscape of possibilities. Embrace diversity, explore, and thrive! Moral of the Story: In the vast landscape of your career, dare to explore beyond the familiar, for it is in diversity that you'll find the richness of opportunities and the key to unlocking your true potential. Ready to explore your own path? Share your unique biotech journey or ask questions in the comments! #BiotechJourney #DiverseOpportunities #CareerInspiration #CareerGuidance #BiotechCareers #STEMCareers #ExploreYourPassion #CareerAdventure #STEMProfessionals #CareerDevelopment #ProfessionalGrowth #BiotechSuccess #InspiringCareers #CareerExploration #STEMLeadership #BiotechTalent #CareerDiversity #InteractiveCareerChat
To view or add a comment, sign in
-
-
Some projects are always special. The Thieme Chemistry #WebCheminar series will always be a special project and milestone for me as a project manager and product owner. The first Thieme WebCheminar took place on February 22nd. In the last 24 months we delivered 23 seminars with renowned chemists from all over the world. During the 23 sessions we received >10K registrations. A big #thankyou to all the registrants and attendees for being a part of this journey. Nothing would have been possible without your support, love, suggestions and active participation. WebCheminar became the go-to platform for staying ahead in the field of chemistry. The series served as a hub for #collaboration, fostering connections and knowledge sharing among chemists around the world. As a chemist by training, the series was a unique experience for me to personally meet some of the brightest and rising stars in the field of chemistry, and I am sure the series empowered many researchers worldwide by providing access to high quality chemical information and educational resources. From accelerating research breakthroughs to empowering the next generation of chemists, WebCheminar played a pivotal role in driving positive change and advancing the field of chemistry. None of this would have been possible without the amazing team working behind the scenes. A big thank you to all the project members i.e. our content team, marketing team, sales team, and to the top management for your continuous support and encouragement. This is truly a great result of successful #teamwork. We believe in #continuousimprovement. That is why we are starting a collaboration with Cassyni, a London-based company that provides a platform for setting up and running online seminars. Cassyni offers several quality features that will make #ThiemeCheminars more interesting and user-centric. One of the most interesting features from our point of view is that the recording of the webinar is cut into chapters by #AI, which makes it easier to view a specific section of the webinar. With its intuitive interfaces, Cheminar will redefine the research learning experience. Through engaging multimedia content and personalized learning paths, users will gain a deeper insights into complex chemical concepts. The first Thieme Cheminar on the Cassyni platform is scheduled for March 27, 2024. I encourage you to join our Thieme Cheminar community on Cassyni: https://lnkd.in/ePghVYvd #chemistryeducation
To view or add a comment, sign in
-
One thing PhD 🎓 does NOT teach you is 💰 and IMPACT it has on Biotech Industry. Every scientist (myself included) needs to be educated about ONE SIMPLE FACT. Science does NOT exist in a Vacuum: Every ounce of our scientific curiosity 👨🎓 needs to be measured against risk/reward in the real world. Every possible patient outcome 🤧 needs to be financially modeled with respect to reimbursement in a quagmire known as US healthcare system. Every piece of our research stack 🔬 will need de-risking and re-evaluation in terms of a commercial licensing agreements, royalties and other instruments of value creation for entire ecosystem. A good molecule that binds a target is merely a top of the iceberg 🏔️. Nay, it’s merely a cap! If you want to be prepared to have a rewarding career in biotech, these principles of money are KEY to building a broader understanding of what REALLY matters. Not to you, but to people who decide your fate, if you’re employed. Educate yourself about Money 💰, and the science will be taken care of by AI 🤖😂 Needless to say: all posts are entirely my opinion, and not of any employer, past or present! #research #biotech #technology #finance #money
To view or add a comment, sign in
-
-
🎉 Exciting news! 🎓 I'm thrilled to share that I've successfully completed the "Industrial Biotechnology" course from the prestigious University of Manchester on Coursera! 🌟 Despite life's busy schedule, I dedicated time to enhance my knowledge in this cutting-edge field, and the journey has been incredibly rewarding. 💼 🔬 Throughout the course, I delved into the fascinating world of industrial biotechnology, exploring topics such as microbial genetics, fermentation processes, bioreactor design, and bioinformatics. 💡 The hands-on assignments and insightful lectures provided by experts in the field have broadened my understanding and equipped me with practical skills that I can apply in real-world scenarios. 🌐 🌱 Armed with this newfound knowledge, I'm eager to contribute to the ever-evolving landscape of biotechnology, driving innovation, sustainability, and positive change. 💪 Let's continue to harness the power of biotechnology to address global challenges and create a brighter future for generations to come. 🌍 #IndustrialBiotechnology #ManchesterUniversity #Coursera #Biotech #Bioinformatics #Sustainability #Innovation #LifelongLearning #ProfessionalDevelopment #FutureReady
To view or add a comment, sign in
-
-
🧬🎨 Mastering the Art of Science: Balancing Biotechnology Studies with Creative Exploration 💡🔬 🔬 Balancing the Microscope and the Paintbrush 🎨 - Tips for Biotech Students! As a biotechnology student, it’s crucial to maintain a balance between your rigorous studies and your creative pursuits. 🧬✏️ Here are some tips to keep the creativity flowing while excelling in your studies: 1. 📚 Schedule Wisely: Allocate specific times for studies and creative activities. This helps in maintaining focus and reducing burnout. 2. 🧪 Experiment Creatively: Apply your artistic skills in your biotech projects. It could be as simple as creatively presenting your research findings. 3. 🌱 Nature’s Inspiration: Take inspiration from nature for both your scientific and creative work. The natural world is full of patterns and designs that fuel both realms. 4. 🤝 Collaborate: Work with peers from creative fields. This can lead to innovative ideas and projects that blend science with art. 5. 💡 Stay Curious: Always keep your curiosity alive. Whether it's a new scientific theory or an art technique, be open to learning. Let's bridge the gap between science and creativity! How do you balance your studies and creative passions? Share your thoughts! #BiotechCreativity #StudentLife #ScienceMeetsArt
To view or add a comment, sign in
-
-
Teaching #biotech? Here we share 3 simple strategies for tailoring #scienceeducation to multiple learning styles: https://lnkd.in/eQhftX6d
Tap into different learning styles in the science classroom
https://www.minipcr.com
To view or add a comment, sign in
-
Teaching scientists how to work in/with industry | Transforming how scientists see their careers | Author | Speaker | Entrepreneur and startup mentor
⚛️ ⚗️ 🔬Are you a science researcher considering building a lucrative partnership with industry? 👍 That’s a great idea. I help lots of scientists grow their research funding by doing this. But if you are planning to showcase the awesome science you are doing to attract their attention, well…that’s 𝙣𝙤𝙩 such a great idea. I call this the ‘tech transfer myth,’ because many people believe that tech companies look for cool science to add to their product portfolio. But this is rarely the case. Companies already have technology that they are trying to commercialize. What 𝙙𝙤 companies need? They often need help solving the problems that are preventing them from getting their products to market, or preventing them from solving their customers' problems. Can you help them with those problems? Probably so! Sometimes the problems that companies have are outside the expertise or capabilities of the people they’ve hired. That’s when an academic collaborator can be the perfect solution! Want to know more? DM me with the question: ‘How can I get research funding from industry?' #techtransfer #industrycollaboration #scientist #researchfunding
To view or add a comment, sign in
-
Genomics Strategy | Biotech Due Diligence | Biomarkers and Bioinformatics | Principal Consultant
1moAli Divan, Ph.D. A paper or grant CAN be a result, it is just how you frame it